DocuSign: Sign Up Here
DocuSign has fallen to near all-time lows as the growth rate slows following a few strong years with covid. The e-signature company continues to provide tepid guidance while constantly smashing estimates with the next test coming up for FQ1 on June 8. The stock is cheap at 21x FY25 EPS estimates that are likely conservative. This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Learn More » As a covid beneficiary, DocuSign ( NASDAQ: DOCU ) growth is regularly diminished, yet the e-signature company continues to grow beyond the original surge. The company definitely faces a tough macro environment, but DocuSign continues to outperform while providing conservative guidance. My investment thesis remains Bullish on the document company due to the opportunity to expand the TAM into a smart agreement. Read the full article on Seeking Alpha. Disclosure: No position mentioned. Please review the discla...